Type I interferon autoantibodies are associated with systemic immune alterations in patients with COVID-19
Monique G.P. van der Wijst(University Medical Center Groningen), Chun Ye(University of California, San Francisco), Sabrina A Mann(University of California, San Francisco), Alyssa Ward(University of California, San Francisco), Raymund Bueno(University of California, San Francisco), David J. Erle(University of California, San Francisco), Paul Bastard(Inserm), Richard K. Perez(University of California, San Francisco), Tianna Grant(University of California, San Francisco), Carolyn M. Hendrickson(University of California, San Francisco), Matthew F. Krummel(University of California, San Francisco), Michail S. Lionakis(National Institute of Allergy and Infectious Diseases), Arjun A. Rao(University of California, San Francisco), Carina Marquez(University of California, San Francisco), Adrian Gervais(Université Paris Cité), Yichen Si(University of Michigan), Anton Ogorodnikov(University of California, San Francisco), Kathleen Kelly(University of Colorado Denver), John R. Greenland(San Francisco VA Medical Center), Joseph L. DeRisi(University of California, San Francisco), Qian Zhang(Inserm), Jean‐Laurent Casanova(Howard Hughes Medical Institute), George C. Hartoularos(University of California, San Francisco), Yun S. Song(University of California, Berkeley), Philip J. Norris(University of California, San Francisco), Kara L. Lynch(University of California, San Francisco), Bryan Greenhouse(San Francisco General Hospital), Cassandra Yun(University of California, San Francisco), Carolyn S. Calfee(University of California, San Francisco), Gabriel Chamie(University of California, San Francisco), Prescott G. Woodruff(University of California, San Francisco), Diane V. Havlir(University of California San Diego), Sara E. Vazquez(University of California, San Francisco), Larry J. Dumont(Dartmouth College), Alexis J. Combes(Centre National de la Recherche Scientifique), Alexander Whatley(University of California, Berkeley), Kirsten N. Kangelaris(San Francisco General Hospital), Gabriela K. Fragiadakis(University of California, San Francisco), Ashley Byrne(Chan Zuckerberg Initiative (United States)), Mark S. Anderson(University of California, San Francisco), Yang Sun(Nanjing Drum Tower Hospital), Peng Zhang, Tom Le Voyer(Inserm), David Lee(University of California, San Francisco), Charles Langelier(University of California, San Francisco)
Cited by 237
Related Papers
Gene Therapy of Human Severe Combined Immunodeficiency (SCID)-X1 Disease
|Science|2000|2.6k
Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome
|Science|2003|2.6k
Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia
|Science|1997|2.2k
Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy
|New England Journal of Medicine|1997|1.9k